Skip to main content
. 2013 Dec 21;19(47):9012–9019. doi: 10.3748/wjg.v19.i47.9012

Figure 5.

Figure 5

Second malignancies occurred in 472 of 2821 patients with gastroenteropancreatic neuroendocrine tumor. A: The absolute number; B: The percentage of patients with one or more second (non-gastroenteropancreatic neuroendocrine tumor, non-GEP-NET) neoplasms. 0 = No second neoplasm. GEP-NET: Gastroenteropancreatic neuroendocrine tumor.